Publications et rapports
Publications et rapports
Prise en charge thérapeutique des MICI de l'enfant (en savoir +)

Penninck E, Fumery M, Armengol-Debeir L, Sarter H, Savoye G, Turck D, Pineton de Chambrun G, Vasseur F, Dupas JL, Lerebours E, Colombel JF, Peyrin-Biroulet L, Gower-Rousseau C; EPIMAD Group. Postoperative Complications in Pediatric Inflammatory Bowel Disease: A Population-based Study. Inflamm Bowel Dis. 2015 Sep 9. [Epub ahead of print] PubMed PMID: 26355466.

Fumery M, Jacob A, Sarter H, Michaud L, Spyckerelle C, Mouterde O, Savoye G, Colombel JF, Peyrin-Biroulet L, Gower-Rousseau C, Turck D; EPIMAD Group. Efficacy and safety of adalimumab after infliximab failure in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2015 Jun;60(6):744-8.

Gower-Rousseau C, Savoye G, Colombel JF, Peyrin-Biroulet L. Are we improving disease outcomes in IBD? A view from the epidemiology side. Gut. 2014 Oct;63(10):1529-30.

Crombé V, Salleron J, Savoye G, Dupas JL, Vernier-Massouille G, Lerebours E, Cortot A, Merle V, Vasseur F, Turck D, Gower-Rousseau C, Lémann M, Colombel JF, Duhamel A. Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: a population-based study. Inflamm Bowel Dis. 2011 Oct;17(10):2144-52.